What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis …

PC Moldovan, T Van den Broeck, R Sylvester… - European urology, 2017 - Elsevier
Context It remains unclear whether patients with a suspicion of prostate cancer (PCa) and
negative multiparametric magnetic resonance imaging (mpMRI) can safely obviate prostate …

Prevention of prostate cancer morbidity and mortality: primary prevention and early detection

MJ Barry, LH Simmons - Medical Clinics, 2017 - medical.theclinics.com
Disclosure: Dr MJ Barry is President of the Informed Medical Decisions Foundation, a part of
Healthwise, where he is also Chief Science Officer. Healthwise is a 501 (c) 3 nonprofit …

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

H Grönberg, J Adolfsson, M Aly, T Nordström… - The lancet …, 2015 - thelancet.com
Background The prostate-specific antigen (PSA) test is used to screen for prostate cancer
but has a high false-positive rate that translates into unnecessary prostate biopsies and …

Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology clinical practice guideline …

RC Chen, RB Rumble, DA Loblaw, A Finelli… - Journal of Clinical …, 2016 - ascopubs.org
Purpose To endorse Cancer Care Ontario's guideline on Active Surveillance for the
Management of Localized Prostate Cancer. The American Society of Clinical Oncology …

Detecting prostate cancer using deep learning convolution neural network with transfer learning approach

AA Abbasi, L Hussain, IA Awan, I Abbasi, A Majid… - Cognitive …, 2020 - Springer
Prostate Cancer in men has become one of the most diagnosed cancer and also one of the
leading causes of death in United States of America. Radiologists cannot detect prostate …

Long-term results of active surveillance in the Göteborg randomized, population-based prostate cancer screening trial

RA Godtman, E Holmberg, A Khatami, CG Pihl… - European urology, 2016 - Elsevier
Background Active surveillance (AS) has become a well-accepted and widely used
treatment strategy. Objective To assess the long-term safety of AS for men with screen …

Grade migration of prostate cancer in the United States during the last decade

LD Borregales, G DeMeo, X Gu, E Cheng… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Prostate cancer (PC) screening guidelines have changed over the last decade
to reduce overdiagnosis and overtreatment of low-grade disease. We sought to examine …

Missing the mark: prostate cancer upgrading by systematic biopsy over magnetic resonance imaging/transrectal ultrasound fusion biopsy

A Muthigi, AK George, A Sidana, M Kongnyuy… - The Journal of …, 2017 - auajournals.org
Purpose: Multiparametric magnetic resonance imaging and fusion biopsy detect more high
risk prostate cancer and less low risk prostate cancer than systematic biopsy. However …

Support Vector Machines (SVM) classification of prostate cancer Gleason score in central gland using multiparametric magnetic resonance images: A cross-validated …

J Li, Z Weng, H Xu, Z Zhang, H Miao, W Chen… - European journal of …, 2018 - Elsevier
Purpose To assess the performance of Support Vector Machines (SVM) classification to
stratify the Gleason Score (GS) of prostate cancer (PCa) in the central gland (CG) based on …

Magnetic resonance imaging-transrectal ultrasound guided fusion biopsy to detect progression in patients with existing lesions on active surveillance for low and …

TP Frye, AK George, A Kilchevsky, M Maruf… - The Journal of …, 2017 - auajournals.org
Purpose: Active surveillance is an established option for men with low risk prostate cancer.
Multiparametric magnetic resonance imaging with magnetic resonance imaging-transrectal …